These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 23523477

  • 21. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes.
    Freeman J, Vernon J, Morris K, Nicholson S, Todhunter S, Longshaw C, Wilcox MH, Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes' Study Group.
    Clin Microbiol Infect; 2015 Mar; 21(3):248.e9-248.e16. PubMed ID: 25701178
    [Abstract] [Full Text] [Related]

  • 22. Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain.
    Arca-Suárez J, Galán-Sánchez F, Cano-Cano F, García-Santos G, Rodríguez-Iglesias MA.
    Anaerobe; 2018 Dec; 54():146-150. PubMed ID: 30261271
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. An outbreak of Clostridium difficile infections due to new PCR ribotype 826: epidemiologic and microbiologic analyses.
    Crobach MJT, Voor In 't Holt AF, Knetsch CW, van Dorp SM, Bras W, Harmanus C, Kuijper EJ, Vos MC.
    Clin Microbiol Infect; 2018 Mar; 24(3):309.e1-309.e4. PubMed ID: 28830806
    [Abstract] [Full Text] [Related]

  • 25. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
    Piepenbrock E, Stelzer Y, Berger F, Jazmati N.
    Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1.
    Tratulyte S, Miciuleviciene J, Kuisiene N.
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1953-1959. PubMed ID: 31327067
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption.
    Seo MR, Kim B, Kim J, Pai H.
    Int J Antimicrob Agents; 2019 Aug; 54(2):154-158. PubMed ID: 31173866
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired clostridium difficile PCR ribotype 018 strains.
    Seo MR, Kim J, Lee Y, Lim DG, Pai H.
    Int J Antimicrob Agents; 2018 May; 51(5):762-767. PubMed ID: 29408226
    [Abstract] [Full Text] [Related]

  • 32. Molecular epidemiology of Clostridium difficile infection in Iranian hospitals.
    Shoaei P, Shojaei H, Khorvash F, Hosseini SM, Ataei B, Tavakoli H, Jalali M, Weese JS.
    Antimicrob Resist Infect Control; 2019 May; 8():12. PubMed ID: 30675339
    [Abstract] [Full Text] [Related]

  • 33. Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel.
    Miller-Roll T, Na'amnih W, Cohen D, Carmeli Y, Adler A.
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):450-454. PubMed ID: 27638350
    [Abstract] [Full Text] [Related]

  • 34. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
    Shoaei P, Shojaei H, Jalali M, Khorvash F, Hosseini SM, Ataei B, Vakili B, Ebrahimi F, Tavakoli H, Esfandiari Z, Weese JS.
    BMC Infect Dis; 2019 Apr 30; 19(1):361. PubMed ID: 31039738
    [Abstract] [Full Text] [Related]

  • 35. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O, Tejkalova R, Kriz Z, Ruzicka F, Kubicek L, Matejkova J, Kuijper E, Krutova M.
    Microb Drug Resist; 2017 Jul 30; 23(5):609-615. PubMed ID: 27860531
    [Abstract] [Full Text] [Related]

  • 36. Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004.
    Taori SK, Hall V, Poxton IR.
    J Med Microbiol; 2010 Mar 30; 59(Pt 3):338-344. PubMed ID: 19942691
    [Abstract] [Full Text] [Related]

  • 37. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M, Szczegielniak A, Wiechuła B, Harmanus C, Kuijper E, Martirosian G.
    Anaerobe; 2017 Jun 30; 45():106-113. PubMed ID: 28216085
    [Abstract] [Full Text] [Related]

  • 38. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan.
    Kuwata Y, Tanimoto S, Sawabe E, Shima M, Takahashi Y, Ushizawa H, Fujie T, Koike R, Tojo N, Kubota T, Saito R.
    Eur J Clin Microbiol Infect Dis; 2015 Apr 30; 34(4):763-72. PubMed ID: 25471195
    [Abstract] [Full Text] [Related]

  • 39. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.
    Hubert B, Loo VG, Bourgault AM, Poirier L, Dascal A, Fortin E, Dionne M, Lorange M.
    Clin Infect Dis; 2007 Jan 15; 44(2):238-44. PubMed ID: 17173224
    [Abstract] [Full Text] [Related]

  • 40. Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases.
    Hung YP, Lin HJ, Tsai BY, Liu HC, Liu HC, Lee JC, Wu YH, Wilcox MH, Fawley WN, Hsueh PR, Tsai PJ, Ko WC.
    Anaerobe; 2014 Dec 15; 30():188-92. PubMed ID: 24956433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.